Announced Wed, 30 Jul · 17:55 IST

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, investment in wholly owned subsidiary

Capex & Operations View source PDF

CLEAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Clean Science and Technology has invested approximately Rs.70 crores in its wholly owned subsidiary Clean Fino-Chem Limited (CFCL) by subscribing to 11,70,569 equity shares at a face value of Rs.10 each with a premium of Rs.588 per share, as part of CFCL's rights issue. This is a continued capital infusion into CFCL, following earlier investments in March 2022, October 2022, February 2024, and January 2025. The capital will be used to fund CFCL's projects. CFCL, incorporated in March 2022, operates in the speciality chemicals space and has shown rapid revenue growth, from nil in FY23 to Rs.1.92 crores in FY24 and Rs.46.77 crores in FY25. The transaction is a related-party deal (parent investing in its own subsidiary) executed at arm's length, paid entirely in cash, and CSTL continues to hold 100% in CFCL.

Likely market impact

This is an internal capital allocation to a wholly owned subsidiary rather than a new external acquisition, so the impact on the listed entity is limited to how effectively CFCL uses this money. Investors should watch CFCL's revenue trajectory and project execution, as continued capital infusions suggest the subsidiary is still in a build-out phase. No immediate effect on share price is expected from this routine funding event.